The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

He and his team then compared the diagnoses for hair loss in these patients’ medical records and found that those prescribed ...

Addiction and obesity share deep neurological roots. Can new treatments like GLP-1 drugs and MEAI help break the cycle?

My son has been overweight his whole life. He is now obese and is asking if he could take the medicine he sees on TV ...

Burke Wealth Management, an investment management company, released its “Focused Growth Strategy” fourth quarter 2024 ...

State lawmakers are considering expanding the types of obesity treatments covered by Nevada Medicaid, including approving ...

Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...

In findings from a microsimulation model published in JAMA Health Forum, semaglutide (Wegovy, Novo Nordisk) had the highest incremental cost-effectiveness ratio (ICER) of four obesity medications ...

A study in people with obesity and diabetes again found CagriSema helps people lose weight, but not by enough to clearly ...

Adults with obesity who have a prescription for Wegovy but do not have insurance coverage for the drug can now purchase the ...

State DHS officials say new weight-loss drugs are driving up costs for Pennsylvania’s Medicaid program, likely leading to ...